1.  Identify and employ lifestyle adjustments (nonpharmacologic measures) and pharmacologic approaches to managing gout

2.   Understand rationales for current urate-lowering therapeutic paradigm for gout

3.   Recognize risks and advantages of currently available urate-lowering agents



Session date: 
04/26/2016 - 8:30am to 9:30am CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™

Please login or create an account to proceed.
Speaker Name: 
Michael A. Becker, M.D.